WVTM 13 Birmingham on MSN10h
8-year-old battles rare blood disorder with support from family and hospital staffSophie Cromer, an 8-year-old from Alabama, has faced a challenging journey after being diagnosed with aplastic anemia at the age of 6. "We started at Sophie's pediatrician, we had her labs checked, ...
Takeda Pharmaceutical Company Limited (NYSE:TAK) entered into an exclusive licensing agreement with Keros Therapeutics, Inc. ...
And God blessed the seventh day and declared it holy—having ceased on it from all the work of creation that God […] ...
Study finds annual healthcare costs per patient are significantly higher than previously described– HHT costs are higher than other ...
Takeda ( TSE:4502/NYSE:TAK) today announced that it has entered into an exclusive licensing agreement with Keros Therapeutics, Inc. (Nasdaq: KROS) to further develop, manufacture and commercialize ...
Keros Therapeutics to receive upfront payment of $200 million and is eligible to receive development, approval and commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback